Amesite Inc (AMST) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed May 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMST SEC filings page.
Amesite Inc (AMST) reported $341K in revenue over the twelve months to Mar 31, 2026, up 313.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Development spending exceeds revenue, while financing supports operations as the reported commercial base shrinks.
Revenue fell33.8% in FY2025 while the operating loss narrowed21.3% ; this is cost reduction amid contraction, not scale-driven operating leverage. Operating cash flow of-$2.5M was less negative than the net loss of-$3.6M , so cash use was lighter than accounting loss, a gap that can reflect noncash charges or working-capital timing rather than earnings converting into cash.
R&D was
FY2025 financing cash flow supplied
Financial Health Signals
Amesite Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Amesite Inc scores -10.01, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($7.0M) relative to total liabilities ($359K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Amesite Inc passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Amesite Inc reported a net loss of $3.6M while operations used $2.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Amesite Inc generated $83K in revenue in Q3 2026. This represents an increase of 171.5% from the same quarter a year earlier. Against the prior quarter it is down 22.9%.
Amesite Inc's EBITDA was -$678K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.5% from the same quarter a year earlier. Against the prior quarter it is up 8.3%.
Amesite Inc reported -$678K in net income in Q3 2026. This represents a decrease of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 7.4%.
Amesite Inc earned -$0.15 per diluted share (EPS) in Q3 2026. This represents an increase of 6.3% from the same quarter a year earlier. Against the prior quarter it is up 6.3%.
Cash & Balance Sheet
Amesite Inc held $641K in cash as of Q3 2026; long-term debt is not reported for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Amesite Inc's ROE was -52.1% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 33.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.
Not reported for Q3 2026.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Amesite Inc invested $134K in research and development in Q3 2026. This represents a decrease of 22.0% from the same quarter a year earlier. Against the prior quarter it is down 18.6%.
Not reported for Q3 2026.
Not reported for Q3 2026.
AMST Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $83K+171.5% | $108K+746.8% | $94K+738.2% | $56K+100.3% | $31K-10.4% | $13K-69.2% | $11K-82.2% | $28K-77.4% |
| R&D Expenses | $134K-22.0% | $165K-22.2% | $103K-26.3% | $168K-9.8% | $172K-23.1% | $212K-36.0% | $140K-58.1% | $186K |
| SG&A Expenses | $550K+28.3% | $579K-28.1% | $547K-13.6% | $612K-31.4% | $428K-62.2% | $805K+81.3% | $633K+44.5% | $891K+63.0% |
| Operating Income | -$684K+0.5% | -$745K+34.1% | -$662K+28.6% | -$858K+29.1% | -$688K+53.0% | -$1.1M-18.3% | -$927K+2.4% | -$1.2M-22.8% |
| EBITDA | -$678K+0.5% | -$739K+34.3% | -$602K+25.6% | -$555K+49.1% | -$681K+49.2% | -$1.1M-37.7% | -$809K-1.4% | -$1.1M-31.7% |
| Net Income | -$678K-2.2% | -$733K+34.7% | -$642K+29.3% | -$924K+21.8% | -$663K+53.5% | -$1.1M-23.9% | -$908K-1.9% | -$1.2M-24.5% |
| EPS (Basic) | -$0.15+6.3% | -$0.16+60.0% | -$0.14+58.8% | -$0.18+60.9% | -$0.16+71.4% | -$0.40-11.1% | -$0.34+2.9% | -$0.46-24.3% |
| EPS (Diluted) | -$0.15+6.3% | -$0.16 | -$0.14 | -$0.18 | -$0.16 | -$0.40-11.1% | -$0.34+2.9% | -$0.46-24.3% |
| Diluted Shares (Avg) | N/A | N/A | N/A | N/A | 4M | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense, Income Tax.
AMST Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.5M-60.8% | $2.0M-6.5% | $2.6M-18.1% | $3.1M-6.5% | $3.8M-0.7% | $2.1M-53.1% | $3.2M-42.5% | $3.3M-47.8% |
| Current Assets | $822K-73.8% | $1.3M-7.9% | $1.9M-21.6% | $2.4M-2.8% | $3.1M-0.4% | $1.4M-62.5% | $2.4M-48.6% | $2.5M-54.3% |
| Cash & Equivalents | $641K-77.6% | $1.2M+124.2% | $1.8M+27.6% | $2.3M+12.7% | $2.9M-3.8% | $520K-85.8% | $1.4M-69.1% | $2.1M-60.6% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $19K+327.4% | $7K | $10K | $6K-78.9% | $4K | N/A | N/A | $30K+100.4% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $190K-9.9% | $490K-44.9% | $428K-49.3% | $359K-55.1% | $211K-0.4% | $889K+405.1% | $843K+220.1% | $798K+200.9% |
| Current Liabilities | $190K-9.9% | $490K-44.9% | $428K-49.3% | $359K-55.1% | $211K-0.4% | $889K+405.1% | $843K+220.1% | $798K+200.9% |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | $1.3M-63.8% | $1.5M+20.9% | $2.2M-6.9% | $2.7M+8.9% | $3.6M-0.7% | $1.2M-71.5% | $2.3M-55.6% | $2.5M-58.7% |
| Retained Earnings | -$43.5M-7.3% | -$42.8M-7.4% | -$42.1M-8.7% | -$41.5M-9.6% | -$40.5M-10.6% | -$39.9M-13.2% | -$38.7M-12.9% | -$37.8M-13.2% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
AMST Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$449K+33.7% | -$621K+27.0% | -$416K+14.8% | -$439K+32.8% | -$677K-16.4% | -$850K+7.5% | -$488K+25.9% | -$654K+1.7% |
| Depreciation & Amortization | $6K0.0% | $6K0.0% | $60K-48.9% | $303K+153.5% | $6K-94.8% | $6K-95.5% | $118K-22.4% | $119K-23.8% |
| Stock-Based Compensation | $72K+150.0% | $72K+76.2% | $72K+10.4% | N/A | -$145K | $41K | $65K+18.8% | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$654K+4.8% |
| Investing Cash Flow | -$76K+5.2% | -$44K+32.5% | -$88K+40.8% | -$86K+41.5% | -$80K+27.2% | -$65K-19.3% | -$148K-127.0% | -$147K-43.8% |
| Financing Cash Flow | N/A | N/A | N/A | $0 | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AMST Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -820.9% | -689.7% | -702.2% | -1538.2% | -2240.9% | -8862.6% | -8243.1% | -4344.9% |
| Net Margin | -813.7% | -678.0% | -681.1% | -1657.1% | -2161.7% | -8790.3% | -8071.5% | -4241.4% |
| Return on Equity | -52.1%-33.6pp | -48.6%+41.3pp | -29.6%+9.4pp | -33.7%+13.2pp | -18.4%+20.9pp | -89.9%-69.2pp | -39.0%-22.0pp | -46.9%-31.4pp |
| Return on Assets | -45.4%-28.0pp | -36.7%+15.9pp | -24.7%+3.9pp | -29.8%+5.8pp | -17.4%+19.8pp | -52.5%-32.6pp | -28.6%-12.5pp | -35.6%-20.7pp |
| Current Ratio | 4.33-10.6x | 2.72+1.1x | 4.46+1.6x | 6.79+3.7x | 14.880.0x | 1.63-20.3x | 2.88-15.1x | 3.14-17.5x |
| Debt-to-Equity | 0.15+0.1x | 0.32-0.4x | 0.20-0.2x | 0.13-0.2x | 0.060.0x | 0.71+0.7x | 0.36+0.3x | 0.32+0.3x |
| Asset Turnover | 0.060.0x | 0.050.0x | 0.040.0x | 0.020.0x | 0.010.0x | 0.010.0x | 0.000.0x | 0.010.0x |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -2350.3% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Amesite Inc AMST | FY2025 | $110K | -$3.6M | N/A | $7.0M | — |
| NextPlat NXPL | FY2025 | $54.3M | -$10K | 0.0% | $24.2M | 40/100 |
| Lucas GC Limited LGCL | FY2025 | $149.0M | $1.4M | 0.9% | $1.3M | 41/100 |
| CXApp CXAI | FY2025 | $4.6M | N/A | N/A | $8.0M | 24/100 |
| Smith Micro Software Inc SMSI | FY2025 | $17.4M | -$30K | -0.2% | $15.9M | 39/100 |
| HEARTCORE ENTERPRISES INC HTCR | FY2025 | $9.0M | $5.8M | 64.6% | $3.0M | 37/100 |
Where Amesite Inc Ranks
Frequently Asked Questions
What is Amesite Inc's annual revenue?
Amesite Inc (AMST) reported $110K in total revenue for fiscal year 2025. This represents a -33.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Amesite Inc's revenue growing?
Amesite Inc (AMST) revenue declined by 33.8% year-over-year, from $167K to $110K in fiscal year 2025.
Is Amesite Inc profitable?
No, Amesite Inc (AMST) reported a net income of -$3.6M in fiscal year 2025.
What is Amesite Inc's EBITDA?
Amesite Inc (AMST) had EBITDA of -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Amesite Inc's return on equity (ROE)?
Amesite Inc (AMST) has a return on equity of -132.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Amesite Inc's operating cash flow?
Amesite Inc (AMST) recorded an outflow of $2.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Amesite Inc's total assets?
Amesite Inc (AMST) had $3.1M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Amesite Inc spend on research and development?
Amesite Inc (AMST) invested $691K in research and development during fiscal year 2025.
What is Amesite Inc's current ratio?
Amesite Inc (AMST) had a current ratio of 6.79 as of fiscal year 2025, which is generally considered healthy.
What is Amesite Inc's debt-to-equity ratio?
Amesite Inc (AMST) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Amesite Inc's return on assets (ROA)?
Amesite Inc (AMST) had a return on assets of -116.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Amesite Inc's P/E ratio?
Amesite Inc (AMST) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to March 31, 2026). The market capitalization is $7.0M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Amesite Inc's price-to-sales ratio?
Amesite Inc (AMST) trades at 20.5x sales, its market capitalization divided by revenue of $341K revenue, trailing 12 months to March 31, 2026. The market capitalization is $7.0M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Amesite Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Amesite Inc (AMST) held $2.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.5M over that year. Dividing the one by the other, the reported balance equals about 11 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Amesite Inc's Altman Z-Score?
Amesite Inc (AMST) has an Altman Z-Score of -10.01, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Amesite Inc's Piotroski F-Score?
Amesite Inc (AMST) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Amesite Inc's earnings high quality?
Amesite Inc (AMST) reported a net loss of $3.6M while operations used $2.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.